Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: IEEE Trans Radiat Plasma Med Sci. 2019 Jul 23;4(2):170–183. doi: 10.1109/trpms.2019.2930362

Compact Method for Proton Range Verification Based on Coaxial Prompt Gamma-Ray Monitoring: a Theoretical Study

F Hueso-González 1, T Bortfeld 1
PMCID: PMC7111431  NIHMSID: NIHMS1573369  PMID: 32258856

Abstract

Range uncertainties in proton therapy hamper treatment precision. Prompt gamma-rays were suggested 16 years ago for real-time range verification, and have already shown promising results in clinical studies with collimated cameras. Simultaneously, alternative imaging concepts without collimation are investigated to reduce the footprint and price of current prototypes. In this manuscript, a compact range verification method is presented. It monitors prompt gamma-rays with a single scintillation detector positioned coaxially to the beam and behind the patient. Thanks to the solid angle effect, proton range deviations can be derived from changes in the number of gamma-rays detected per proton, provided that the number of incident protons is well known. A theoretical background is formulated and the requirements for a future proof-of-principle experiment are identified. The potential benefits and disadvantages of the method are discussed, and the prospects and potential obstacles for its use during patient treatments are assessed. The final milestone is to monitor proton range differences in clinical cases with a statistical precision of 1 mm, a material cost of 25000 USD and a weight below 10 kg. This technique could facilitate the widespread application of in vivo range verification in proton therapy and eventually the improvement of treatment quality.

Keywords: proton therapy, range verification, prompt gamma rays, radiation detectors, coaxial, compact

I. Introduction

THE number of cancer patients treated worldwide with proton beams has increased from ~6000 per year in 2007 to ~20000 per year in 2017 [1]. Paired with the advance in beam delivery and treatment planning techniques, the number of hospitals with a proton therapy facility increases annually, up to ~80 in 2019. The essential advantage of proton beams over conventional radiotherapy is their increased ionization density (Bragg peak) and sharp distal falloff near their maximum penetration depth [2], [3]. It is estimated that ~10% of all cancer patients, particularly children, could benefit from proton therapy [4], [5]. However, there is no standardized or commercial method applied in all proton therapy facilities to verify in real-time where protons stop within the patient [6]. This inherent range uncertainty [7] limits to some extent the potential of protons to conform the dose to the tumor. Currently, it forces the application of field patching techniques and conservative safety margins [8] during treatment planning, of up to ~10 mm [9]. A robust treatment plan [10] can ensure tumor coverage even in the case of proton range deviation, but at the cost of a higher integral dose to normal surrounding tissue [11, Fig. 5].

Fig. 5.

Fig. 5.

Solid line: Relative change ΔΩ of measured γ-rays as a function of proton range Rw for an error δz = 1 mm in phantom position, cf. eq. 13, for the coaxial detection setup described in fig. 1 and table I. Dashed line: Statistical measurement precision Δs, cf. eq. 18, for a spot cluster with Np = 108 protons.

Thanks to the efforts of many research institutions during the last decades, several solutions towards in vivo range verification have been proposed and tested [6], [12]. Two examples thereof are Positron Emission Tomography (PET) [13] and Prompt Gamma-ray Imaging (PGI) [14]. The first one has been extensively tested in clinical settings, but is challenged by the correlation of activity to dose as well as the metabolic washout effect [12], [15], except in the case of in-beam PET of short-lived nuclides [16].

The second technique, proposed in 2003 [17], has shown promising advances in recent years [18]. First clinical tests were done with a knife-edge slit PGI camera [19], [20], and a clinical study with a Prompt Gamma-ray Spectroscopy (PGS) camera [21] is foreseen. Both camera prototypes rely on a passive collimation of prompt γ-rays (with energies up to ~6 MeV) and are able to detect the proton range in clinical conditions with a few millimeters precision.

The higher costs of proton therapy with respect to conventional radiotherapy also limit its applicability [3]. There have been efforts from research institutions and industrial partners to reduce the size of proton accelerators [22], [23] as well as the overall price of facilities [24], [25]. Likewise, there is a trend in the field of proton range verification to reduce both the cost and size of currently available prototypes by proposing innovative detection approaches. Collimated systems like the PGI and PGS cameras deploy thick tungsten collimators, that contribute substantially to the overall system weight and footprint. Indirectly, it also increases the costs due to the need of an accurate positioning and rotation system sustaining this weight near the patient. In response to this drawback, uncollimated range verification systems have been proposed and are under investigation [26]–[29]. Their smaller footprint and weight could eventually facilitate the clinical translation.

This article is framed in this context: The need for providing a range verification system in every treatment room of every proton therapy facility at an affordable cost. To that extent, the experience from the current clinical prototypes is essential, but innovative approaches have to be developed to reduce their weight, price and complexity, while still addressing the required precision and associated technical challenges [30].

The dependency between the number of prompt γ-rays detected per proton (with uncollimated systems) and the beam range was observed in [27, Fig. 9] within the context of Prompt Gamma-ray Timing (PGT), in [31, Fig. 10] using a Compton camera (Cc) setup, as well as in Monte Carlo (MC) simulations [32, Fig. 7]. This information has been incorporated into the proton range reconstruction algorithm in [33, subsection 3.1.4, Fig. 3.14]. This methodology was later isolated and named as Prompt Gamma-ray Peak Integration (PGPI) [28], [34].

Fig. 9.

Fig. 9.

Ratio kγ between all interactions and the subset of those corresponding to prompt γ-rays for the coaxial detection setup described in fig. 1 and table I. The points with error bars represent the results obtained with a TOPAS simulation of Np = 108 histories and an energy deposit threshold of 50 keV, while the solid red line indicates the prediction according to the analytical 1D model, cf. subsection II-E.

Fig. 10.

Fig. 10.

Partial detector count rate N˙d,x due to x = background (green) or x = prompt γ-rays (blue) for the coaxial detection setup described in fig. 1 and table I. The points with error bars represent the results obtained with a TOPAS simulation of Np = 108 histories and an energy deposit threshold of 50 keV, while the solid red line indicates the prediction according to the analytical 1D model, cf. eq. 9.

Fig. 7.

Fig. 7.

Total number of prompt γ-rays Nγ (all energies) emitted per proton as a function of the beam range Rw in the water phantom described in fig. 1 and table I. The corresponding beam energy is indicated in the upper horizontal axis. The points with error bars represent the results obtained with a TOPAS simulation and Np = 108 histories, while the solid red line indicates the analytical model prediction, cf. eq. 2 and table I.

The aim of this paper is to propose a compact range verification method – Coaxial Prompt Gamma-ray Monitoring (CPGM) – that exploits the aforementioned phenomenon. The innovation is the positioning of the detector coaxial to the beam axis and behind the treated area. This enables the determination of proton range deviations with a single detector solely based on the number of γ-rays measured and the total incident protons. The covered solid angle will be maximum directly in front of the detector and decreases with the inverse of the square distance (at first order). Consequently, a proton range overshoot caused by e.g. an unexpected air cavity leads to an increased number of γ-rays measured per incoming proton, and vice versa for a range undershoot.

This manuscript is organized as follows. Section II describes a simple mathematical model and solid angle equations of coaxial radiation detection, that serves to illustrate the proposed method. In section III, the analytical model is evaluated for a clinically relevant test case, that could be verified in a future proof-of-principle experiment. The implications, benefits and disadvantages of CPGM in terms of clinical translation are discussed in section IV, and the main conclusions are summarized in section V.

II. Theory

To provide a theoretical framework showing the potential of the CPGM technique, we investigate a simplified setup with a homogeneous water phantom and a cylindrical monolithic detector located downstream and aligned with the proton beam axis, cf. fig. 1.

Fig. 1.

Fig. 1.

Schematics of the detector setup coaxial to the proton beam incidence direction z and behind a water target of length L. The phantom entrance is at position z0, whereas the detector front face is at position zd > z0 + L. The detector is a monolithic cylindrical crystal of radius r and thickness t. The proton range within the water tank is Rw < L.

In the following subsections, we formulate an approximate mathematical model of the γ-ray emission, transmission, solid angle coverage and γ-ray detection, as well as an estimate of the radiation background, detector count rates and sensitivity to range errors in various clinical scenarios. An overview of the variables and parameters defined throughout this section is presented in Table I.

TABLE I.

Variables and parameters used within the theoretical model of coaxial prompt γ-ray detection, cf. fig. 1.

z beam axis coordinate [mm]
z0 front face position of water target 0 mm
zd front face position of the detector 152 mm
L length of the water phantom 150 mm
Rw proton range in water [mm]
r detector radius ½”
t detector thickness 1½”
Nγ γ-rays emitted per incident proton [ ]
g¯λ prompt γ-ray yield per unit length 6·10−4 mm−1
f¯ distal falloff slope 0.3 mm−1
τ transmission probability [ ]
μ¯w average absorption coefficient of water 10−4 mm−1
Ω/4π relative solid angle subtended [ ]
η probability of interaction in detector [ ]
μ¯d average attenuation coefficient of detector 2·10−2 mm−1
td decay time of the scintillation light pulse 16 ns
Np number of protons within one spot cluster 108
N^d prompt γ-rays detected per proton (theory) [ ]
Nd prompt γ-rays detected per spot (theory [ ]
Md prompt γ-rays measured per spot cluster [ ]
k¯γ ratio between all counts and the prompt γ-rays 2.5
N˙d,all overall detector count rate [Mcps]
Ip the proton beam (peak) current at the target 2 nA
e elementary charge 1.6·10−19 C
δR absolute error in the proton range Rw 1 mm
δz absolute error in the phantom position z0 1 mm
κ thickness of a cavity within the water target 2 mm
zκ front face position of a cavity within the target [mm]
ΔN relative count variation for a range error δR [ ]
ΔΩ relative count variation for a target error δz [ ]
Δγ γ-ray emission variation for a range error δR [ ]
Δκ relative count variation due to a cavity κ [ ]
Δs statistical measurement uncertainty [ ]
χ background fraction separated by energy filters 0.5
Σt proton bunch time spread (FWHM) 2 ns
Tp proton bunch period 9.4 ns

A. Emission

We assume an analytical One-Dimensional (1D) model of the prompt γ-ray emission (including all energies) characterized by a flat profile and a sharp distal falloff near the proton range Rw. This is a coarse approximation of the energy-integrated depth-emission profile [35, Fig. 6], [36, Fig. 7]. The expression of γ-rays emitted per unit length and incident proton yields:

dNγdz(z;Rw)g¯λ12(1+erf[f¯(Rw(zz0))]) (1)

for z(z0,z0+L), cf. fig. 1. The integral number of emitted γ-rays can be approximated for f¯1Rw by:

Nγ(Rw)=z0z0+LdNγdz(z)dzg¯λRw (2)

Fig. 6.

Fig. 6.

Relative change Δκ of measured γ-rays after introduction of a 2 mm cavity in the beam path, as a function of original proton range Rw and cavity position zκ, cf. eq. 17, for the coaxial detection setup described in fig. 1 and table I. The black dashed line represents the statistical measurement precision Δs, cf. eq. 18, for a spot cluster with Np = 108 protons.

The (approximate) value g¯λ6×104mm1 is the energy-integrated prompt γ-ray yield, namely the number of γ-rays emitted per proton traversing a unit length in water. f¯0.3mm1 is an empirical constant to reproduce the shape of the distal drop-off of the γ-ray emission at the proton range Rw. For simplicity, it is considered to be independent from the initial proton energy. For f¯, the error function becomes a step function and the emission profile is a simple rectangular function [27, Fig. 3].

Fig. 3.

Fig. 3.

Solid line: Relative change ΔN of measured γ-rays as a function of proton range Rw for an error δR = 1 mm, cf. eq. 11, for the coaxial detection setup described in fig. 1 and table I. Dashed line: Statistical measurement precision Δs, cf. eq. 18, for a spot cluster with Np = 108 protons.

B. Transmission

The prompt γ-rays emitted towards the detector might be absorbed, scattered or undergo pair production within the water phantom. The transmission probability is approximated as a function of the energy-dependent absorption coefficient μw(E) [37] and the traversed path. As a first order approximation, we use a value μ¯w104mm1 that is the sum of the photoelectric absorption and pair production coefficients averaged over the energy range of interest. For the setup described in fig. 1, the transmission probability τ(z) of a ray emitted at a depth z ∈ (z0, z0 + L) and traveling towards the detector is given by:

τ(z)=exp[μ¯w(L(zz0))] (3)

Compton scattering is not included, as high energy γ-rays are likely to scatter in forward direction [33, Fig. 2.4] and thus might still impinge the detector. On the other hand, annihilation photons (following pair production) are less likely to escape the phantom and reach the detector, due to the three times higher attenuation coefficient in water compared to 4 MeV photons [37], as well as due to their isotropic emission distribution; hence their contribution is neglected.

C. Solid angle

The influence of detector position and solid angle covered with respect to an irradiation source has been comprehensively studied in [38], [39], and was investigated specifically for the PGI field by means of MC simulations [32], [40], [41]. Here, we adopt the analytical solution for an ideal cylindrical detector of thickness t and radius r, aligned with the beam axis.

For a γ-ray emitted isotropically at a depth z ∈ (z0, z0 + L), the relative solid angle Ω/4π subtended by the front face of the detector located at position zd yields:

Ω4π(z;zd)=12(111+r2/(zdz)2) (4)

D. Detection

For a γ-ray crossing the detector, the interaction probability depends on the crystal thickness t and the energy-dependent attenuation coefficient μd(E) [37]. In the paraxial approximation, and using an averaged attenuation coefficient μ¯d, the interaction probability (including scattering) yields:

η=1exp[μ¯dt] (5)

A fast scintillation crystal like LaBr3 with an average attenuation coefficient of μ¯d2×102mm1 [37] and a decay time td of 16ns [42] is chosen as detector. The monolithic scintillation crystal has a diameter (2r) of 1” and a thickness (t) of 1½”.

The number of prompt γ-rays N^d measured by the detector at a position zd for each incident proton with a range Rw follows from the multiplication of production dNγ/dz, transmission τ, solid angle Ω and detection η probabilities, summed across the target:

N^d(Rw,zd)z0z0+LdNγdz(z;Rw)τ(z)Ω4π(z;zd)ηdz (6)

For a pencil beam delivering Np protons, the total prompt γ-ray counts Nd are given by:

Nd=N^dNp (7)

It is common practice in Pencil Beam Scanning (PBS) to aggregate data from neighboring spots [20], [21], [43] in order to achieve around Np ~ 108 protons per cluster. Since the lateral spread of the pencil beam close to the proton range is often larger than the lateral separation between pencil beams, an improvement in statistical precision can be achieved without significant loss in lateral resolution.

In the case of accurately characterized phantoms, and well-known prompt γ-ray yield, detector efficiency and position, the absolute proton range Rw can be reconstructed by minimizing the deviation between measured Md and theoretically expected (eq. 6) prompt γ-ray counts:

argminRw|MdN^d(Rw)Np| (8)

E. Radiation background

In addition to the prompt γ-ray signal, a large radiation background is impinging on the detector. It is induced by neutron interactions as well as material activation (e.g. positron emitting isotopes). Due to the time correlation between the γ-ray signal and the cyclotron Radio Frequency (RF), the background can be reduced [35], [44], [45], or subtracted via dedicated algorithms using timing and energy filters [21]. However, even then, the background events are still important for quantifying the overall detector load. The actual background is difficult to model and depends on the incident proton energy, the target composition, as well as the detector location and other elements in the treatment room. Based on previous measurements in a clinical scenario [21], [46], [47] as well as simulations [35, Fig. 6], the average ratio between overall events and prompt γ-rays can be roughly estimated with k¯γ2.5 for the current setup in coaxial orientation and without collimator, cf. fig. 1. It is assumed that an event can only be detected if it deposits at least 50 keV in the detector.

F. Detector count rate

The beam current in a proton therapy facility is a critical factor challenging the electronics and affecting the feasibility of PGI devices [30], [31]. For the widespread Cyclone ®(C230) isochronous cyclotron of IBA (Louvain-la-Neuve, Belgium), the instantaneous proton beam current Ip is approximately constant at 2 nA [48] at the beam exit window. Correspondingly, the overall detector count rate N˙d,all including background is:

N˙d,allk¯γN^dIpe (9)

where e is the elementary charge.

G. Test case

We defined the irradiation of a brain tumor from a horizontal incidence angle and with the patient couch perpendicular to the beam axis as benchmark case representative for a clinical proton treatment. This treatment site is included among the accepted indications [49], [50] of proton therapy, and the chosen beam incidence and couch angles are frequent in clinical treatment plans [51], [52].

To resemble this geometry in our model, cf. fig. 1, we choose the water tank length L to be equal to the average human head breadth of 150 mm [53]. The detector is located at a distance zd = 152 mm from the beam entrance point z0 = 0 mm.

H. Sensitivity to range errors

The sensitivity of the CPGM method to proton range deviations can be studied analytically by calculating the derivatives of eq. 6 with respect to parameters of interest. For example, the relative variation ΔN of the number of detected γ-rays N^d for an error δR in the proton range in water Rw, caused by an error in the initial proton energy, is given by:

ΔN1N^dN^dRw(Rw)δR (10)
=δRN^dz0z0+Lg¯λf¯πef¯2Rw2(zz0)2τΩ4πηdz (11)

Intuitively, a deviation δR > 0 of the range Rw (higher proton energy) results in a higher number of detected counts due to an increased region of γ-ray production and a larger subtended solid angle for points closer to the detector. A third, minor reason is the shorter attenuation path for γ-rays emitted closer to the detector. To disentangle the two main contributions, two further partial derivatives are calculated.

For the contribution of the subtended solid angle, we study the relative count variation ΔΩ for an error δz in the phantom position z0, while keeping the same proton range and detector position zd. For symmetry, this analysis is comparable to the study of an error −δz in the detector position zd with a fixed phantom position z0.

ΔΩ1N^dN^dzd(zd)δz (12)
=δzη2N^dz0z0+LdNγdzτr2dz(zdz)3(1+r2(zdz)2)1.5 (13)

For the second effect, namely the increase in the region of prompt γ-ray production, we analyze the relative variation Δγ in the integral γ-ray emission Nγ, cf. eq. 2, for an error δR in the proton range Rw:

Δγ1NγNγRw(Rw)δR (14)
δRRw (15)

A more clinically realistic scenario is studied: the introduction of an air cavity of thickness κ = 2 mm within the homogeneous water target (length L is unchanged), cf. fig. 1, with its front face located at a position zκ < z0 + Rw, where zκz0 + κ < L. Neglecting the γ-ray production in air, the prompt γ-ray detection N^d,κ per unit proton in this heterogeneous geometry is derived from:

N^d;κ=z0z0+LΩ4π(z;zd)ηdz{dNγdz(z;Rw)τ(z+κ),z<zκ0,z[zκ,zκ+κ]dNγdz(z;Rw+κ)τ(z),z>zκ+κ (16)

and the relative difference in counts with respect to the nominal target follows from:

Δκ=N^d;κ/N^d;01 (17)

In any of the presented scenarios, the statistical precision of the measurement is essential to detect small range errors. According to Poisson statistics and including partial suppression of background events based on energy and timing filters [45], the relative uncertainty Δs yields:

Δs=1Nd1+(1χ)ΣtTp(k¯γ1) (18)

where χ ≈ 0.5 is the fraction of background events that can be separated from prompt γ-rays based on energy filters, Σt ≈ 2 ns is the proton bunch time Full Width at Half Maximum (FWHM) measured for the C230 cyclotron [54], and Tp = 9.4 ns is the proton bunch period, i.e. the inverse of the cyclotron RF.

I. Validation

The developed analytical model is compared with MC simulations by means of the TOPAS software [55], version 3.2, which is based on the Geant4 10.05.p01 toolkit [56]. The proton beam has a lateral spread of 5 mm, no energy or angular spread, and propagates towards the water phantom. The proton beam kinetic energy is varied between 1 and 125 MeV in steps of 1 MeV, and is correlated to the Continuous Slowing Down Approximation (CSDA) proton range Rw in water via [57]. For every beam energy, Np = 108 histories are generated. The default physics lists are deployed, and a cutoff of 0.5 mm is set for all particles.

The water target is a cylinder with 200 mm diameter and L = 150 mm length. The environment surrounding the target is set to air. The detector is modeled as a cylinder made of LaBr3 and is located as described in fig. 1 and table I.

Two different energy deposit scorers (with 1000 bins between 0 and 10 MeV) are defined in the detector volume. The first one scores particles (mainly photons) stemming from a neutron or positron interaction (background), e.g. γ-rays due to neutron capture on hydrogen; the second one records the rest (signal), i.e. prompt γ-rays. A detector sensitivity threshold of 50 keV is applied in the posterior analysis. A third scorer is defined in order to track the total number of prompt γ-rays emitted across the beam path.

For a beam energy of 100 MeV, a dedicated phase space scorer of emitted prompt γ-rays (stemming from proton inelastic reactions) is defined, in order to obtain a differential (energy-integrated) emission profile dNγ/dz along the z axis, to be compared against eq. 1.

III. Results

In fig. 2, the overall detector count rate N˙d,all as a function of the proton range Rw is calculated for the proposed coaxial detection setup, cf. fig. 1 and table I. As expected, the higher the incoming proton energy (penetration depth), the larger the count rate in the detector due to an increased γ-ray production, solid angle subtended, and decreased attenuation path. The dashed lines indicate the virtual count rate in case of a target alignment error of ±2 mm (across the beam axis). The red data points correspond to selected proton ranges (beam energy layers). Their horizontal error bar is set to 0.5 mm (commissioning tolerance), while the vertical error represents the predicted statistical uncertainty Δs×N˙d,all assuming Np = 108 protons per spot cluster.

Fig. 2.

Fig. 2.

Modeled γ-ray count rate N˙d,all as a function of proton range Rw, cf. eqs. 6 and 9, of a ø1×1½ LaBr3 detector located on the beam axis behind a 150 mm long water phantom, as described in fig. 1 and table I. The proton beam current at the target is Ip = 2 nA and the number of protons per spot cluster is Np = 108. The solid line refers to the nominal situation, whereas the dashed lines correspond to the results expected for a virtual target misalignment of ± 2 mm (along the beam axis). The red points are selected proton ranges accompanied with 0.5 mm horizontal error bars, and with vertical error bars that represent the statistical uncertainty Δs×N˙d,all according to the collected prompt γ-ray counts per spot, cf. eqs. 7 and 18.

The relative variation of the solid curve in fig. 2 is depicted in fig. 3 as a function of proton range Rw, cf. eq. 11. In this case, the statistical uncertainty Δs is superimposed as a dashed line, and imposes a theoretical precision limit for a spot cluster with Np = 108 protons. The concave shape of the solid curve is mainly due to the interplay of two effects: the slower (relative) rise in γ-ray production with proton range for deeper irradiation points and the faster increase of the solid angle subtended by the detector.

Both contributions are isolated in figs. 4 and 5, respectively, by calculating the partial derivatives of eqs. 15 and 13. The combination of both effects leads to the shape visible in fig. 3. It should be noted that, in the case of fig. 5, a target misalignment of 1 mm would not be measurable for a proton range below 60 mm. The reason is that the statistical measurement uncertainty, considering 108 delivered protons, is larger than the expected change in the prompt γ-ray signal.

Fig. 4.

Fig. 4.

Solid line: Relative change Δγ of emitted γ-rays as a function of proton range Rw for an error δR = 1 mm, cf. eq. 15. Dashed line: Statistical measurement precision Δs, cf. eq. 18, for the coaxial detection setup described in fig. 1 and table I, and for a spot cluster with Np = 108 protons.

The variation in detected counts Δκ due to the introduction of an air cavity (thickness κ = 2 mm) in beam direction with respect to the homogeneous scenario is presented in fig. 6. The dashed black curve represents the boundary above which the expected count variation Δκ is below the statistical measurement precision Δs at that abscissa Rw. For the majority of proton ranges Rw and cavity positions zκ, the expected count change is higher than the statistical measurement uncertainty for Np = 108 delivered protons.

In fig. 7, the number of prompt γ-rays emitted per proton as obtained with a TOPAS MC simulation (black dots) is depicted and compared with the proportional estimation g¯λRw of the analytical model (red solid line), cf. eq. 2. The model shape, with a fixed parameter g¯λ=6×104, is a rough first-order approximation of the simulated depth-emission profile obtained. The model underestimates the slope of the curve by 30% for small proton ranges and overestimates it by 30% at larger proton ranges.

The choice of a constant value g¯λ implies that the predicted prompt γ-ray emission distribution is flat, except for the smooth falloff near the particle range according to parameter f¯, cf. eq. 1. For an incident proton energy of 100MeV, this approximation (solid red line) is compared with a TOPAS MC simulation (black dots) of the differential prompt γ-ray production, cf. fig. 8. The modeled profile overestimates the emission about 20% from the TOPAS simulation and underestimates it by 30% close to the proton range Rw (vertical purple line).

Fig. 8.

Fig. 8.

Number of prompt γ-rays Nγ (all energies) emitted per proton and unit length as a function of the penetration depth zz0 within the water phantom described in fig. 1 and table I. The incident beam energy is 100 MeV, corresponding to a proton range in water of Rw = 76.4 mm (vertical purple line). The points with error bars represent the results obtained with a TOPAS simulation and Np = 108 histories, while the solid red line indicates the analytical model prediction, cf. eq. 1 and table I.

The ratio between all events detected and the subset of those that are prompt γ-rays is shown in fig. 9, where the TOPAS MC simulation (black dots) is compared with the constant estimate k¯γ=2.5 of the analytical model (solid red line), cf. subsection II-E. The model overestimates the amount (ratio) of background for all proton ranges; the smaller the proton range, the higher the deviation with respect to the simulation. A similar trend is observed in fig. 10, where the detector count rates due to background (green) and prompt γ-rays (blue) are shown for both the MC simulation and the analytical model, cf. eq. 9.

IV. Discussion

The proposed method for range verification in proton therapy exploits the strong dependency of the integral number of measured γ-rays on proton range. The key innovation of the CPGM approach with respect to PGPI [28] is the coaxial detector orientation and the positioning behind the treated area. This is a convenient geometry to maximize the detection efficiency for γ-rays produced near the Bragg peak. If the number of incident protons, the prompt γ-ray yield, the phantom material and the detector response are well known, the proton range can be inferred by solely counting the number of prompt γ-rays detected within a broad energy window.

A. Limitations

The formulated 1D model, cf. section II, aims at a simplified analytical description of the prompt γ-ray emission and detection based on rough estimates, in order to assess the feasibility of the CPGM method. A number of approximations and limitations are identified:

  • Three-Dimensional (3D) information is not taken into account, e.g. the lateral spread of the proton pencil beam as a function of penetration depth.

  • The energy spread of the incident proton beam is not modeled.

  • A simplified γ-ray emission profile is assumed with a shape independent of proton energy, cf. eq. 1, and an approximate γ-ray yield is used.

  • Characteristic γ-ray lines and Doppler broadening are not considered.

  • γ-ray anisotropy effects are not incorporated [58], [59, Fig. 3], [60, Fig. 2], [61].

  • An ideal homogeneous water phantom is chosen as target.

  • The effect of Computed Tomography (CT) imaging uncertainties on attenuation coefficients and stopping power conversion are not modeled.

  • The dependency of attenuation coefficients on γ-ray energy is not taken into account.

  • Scattering of prompt γ-rays before reaching the detector is neglected, which is however significant at low γ-ray energies (less forward-peaked) and large distances between scattering point and detector.

  • Detection of prompt annihilation photons, stemming from prompt γ-rays that undergo pair production in the phantom, is not considered.

  • A simple model of the radiation background is adopted.

  • Neutron interactions and activation in the detector [62], [63] are not included.

  • The detector response (γ-ray energy deposit) is not included, and the paraxial approximation is used.

  • Second-order corrections needed for PBS, as spots are not coaxial (in general) with the room isocenter (detector axis), are not incorporated.

  • A potential systematic error in the incident number of protons is not accounted for.

  • The statistical error in the stochastic process of γ-ray transmission is not considered.

  • Bias due to systematic errors in the background subtraction is not investigated.

  • Sensitivity to range errors is studied only for simplified cases: global beam range errors (proton energy), target shifts (across beam direction) and local 2 mm air cavities.

B. Sensitivity to range errors

The sensitivity to range errors is studied for a representative brain tumor irradiation from a horizontal beam angle. With a single ø1×1½ scintillation detector, changes of over 3% in the prompt γ-ray count are expected for an absolute proton range error of δR = 1 mm, cf. fig. 3. In the case of 108 delivered protons, the statistical measurement precision would be enough to detect that variation with significance (1σ).

On the other hand, the proposed setup would only be able to detect a target misalignment across the beam axis of δz = 1 mm for proton ranges larger than 6 cm, cf. fig. 5. For smaller proton ranges, the sensitivity would be rather 2 mm, (unless a larger spot cluster or a bigger detector were deployed). A 2 mm precision would be still an improvement compared with the safety margins currently applied [9], [52].

A potential improvement might be the use of a second detector in an upstream orientation and slightly off beam axis, close to the beam entrance point, so that the maximum covered solid angle is in the region where the downstream detector is less sensitive. By combining information from both detectors, complementary information about the absolute target position could be deduced.

The effect of anatomy changes in the patient with respect to the planning CT scan [64] is investigated by adding air cavities of κ = 2 mm thickness within the beam path, cf. fig. 6. If the cavity is located close to the end of range, the statistical measurement precision is not enough to detect this effect, in part because most of the dose has already been deposited in the expected region. For large proton ranges and cavity locations in the beginning of or amid the beam path, count rate variations of 4% are expected, which are higher than the statistical uncertainty for spots with 108 protons.

In the clinical context, where extended targets are irradiated with PBS, the detector is kept fixed at the beam isocenter. This implies that the scanned pencil beam is no longer coaxial to the detector, which reduces the sensitivity of the CPGM method to range errors. The geometrical distance between emission point and detector front face is instead (zdz)2+Δx2=(zdz)/cosα, where Δx is the lateral separation with respect to the beam axis and α is the angle between the z axis and the source-to-detector axis. Hence, at first order in the asymptotic series expansion of eq. 4, the count rate variation ΔΩ due to the solid angle effect is corrected by a factor cos3α=[1+Δx2/(zdz)2]1.5 within the integrand, cf. eq. 13. For example, at a proton range Rw = 100 mm and a lateral separation Δx = 50 mm, the angle α ranges between 10 and 40 degrees across the beam track. Compared to the coaxial case, ΔΩ decreases from 2.5%/mm to 1.4%/mm, still above the statistical precision of 0.8%, cf. fig. 5.

In practice, whether the CPGM method is able to measure 1 mm range shifts with statistical significance depends on the lateral distance of the pencil beam to the isocenter, and on the number of protons within the spot cluster. A comparable kind of inhomogeneous precision depending on the considered spot is also present in other PGI systems oriented perpendicularly to the beam: For spots with the same range and number of protons, but laterally further away from the camera, the solid angle and transmission probability are smaller, so that the number of collected counts (and thus the statistical precision) decreases.

C. Validation

The incorporation of all effects mentioned in subsection IV-A exceeds the scope of this paper and should be subject of either more sophisticated analytical algorithms [65] or a full MC simulation. It should take into account realistic patient geometries, incorporate treatment room elements to reliably simulate neutron-induced background, as well as model accurately the scintillation detector. Consequently, the results presented are a qualitative measure and indicate the potential of the underlying methodology. To assess whether the limitations of the analytical model could invalidate the measurement principle, a TOPAS MC simulation is conducted with a simplified geometry, cf. subsection II-I, mimicking the water target of fig. 1.

The results are compared with the model in view of the most critical approximations and estimates included in the model. If these were off by more than a factor of two, it could jeopardize the feasibility of the CPGM method. Specifically, the linear approximation in the prompt γ-ray production is tested in fig. 7, the flat profile gλ is studied in fig. 8, the constant ratio kγ between all events and prompt γ-rays is presented in fig. 9, and the overall detector count rates is shown in fig. 10.

The fact that the model overestimates the slope in the prompt γ-ray production by 30% at large proton ranges implies a noticeable reduction of the expected count variation Δγ. However, this is a minor effect at large proton ranges compared to the solid angle contribution ΔΩ in case of a global range error, cf. fig. 4. On the other hand, the assumption of a constant ratio kγ = 2.5 is conservative compared to the results obtained with a TOPAS MC simulation. For all proton ranges, the amount of background obtained with TOPAS MC is smaller than predicted. Correspondingly, the modeled detector count rates for prompt γ-rays and background are discrepant with the simulated ones, with maximum deviations of ~0.5 Mcps.

These differences highlight the limitations of the analytical model, but also demonstrate its ability to provide reasonable estimates with coarse approximations in the correct order of magnitude. Being aware that the analytical model is just a simple provisional means and not a goal, and that the MC simulations used as reference might also suffer from large uncertainties [66], [67], this theoretical evaluation aims at illustrating the fundamental principles and potential feasibility of a new range verification strategy. It does not provide a precise validation or proof-of-principle of CPGM, but rather encourages its future verification with experimental measurements in a proton therapy facility, and the development of a MC-based (instead of analytical) detection model, as in [21].

D. Absolute range prediction

Our analysis only investigates the sensitivity to range deviations with respect to a nominal well-known situation. A more difficult requirement would be the prediction of the absolute proton range for the first treatment fraction. In that case, the absolute calibration of the ionization chamber measuring the number of incoming protons Np is very important [68]. Furthermore, the absolute accuracy of the prompt γ-ray production cross sections would be a critical factor (unless a second detector is added in an upstream location, which can partially rule out a systematic error). Currently, there are deviations between measured and reference cross sections of ~20% [21]. Hence, an absolute range verification with CPGM is not realistic in the short to medium term. Extra efforts should be undertaken by a task group within the scientific community, in order to improve the precision down to 2% and to agree on double-differential nuclear reaction cross sections [69] in consensus [70].

Furthermore, as the cross sections are target-specific, a precise estimate of the nuclear composition of the irradiated tissue is needed, or it has to be obtained from the ratios between different γ-ray lines [71] and an underlying MC simulation framework [21]. In this context, it would be also advisable to validate PGI devices within a standardized experiment framework and ground-truth anthropomorphic phantoms [72].

Finally, for the particular case of CPGM, the knowledge about the patient composition behind the irradiated area is also important, as the attenuation of γ-rays until reaching the coaxial detector also affects the number of γ-rays measured. This problem will be less critical when dual-energy CT [73] becomes more commonplace in proton therapy facilities [74], thereby increasing the precision in the characterization of γ-ray attenuation coefficients [75] and elemental concentrations.

E. Detector count rate

The choice of LaBr3 as scintillation material is motivated by its excellent energy resolution and short decay time of 16 ns. The first trait is convenient for the compensation of gain fluctations in the Photomultiplier Tube (PMT) as a function of count rate [76]. The second is extremely important in order to minimize the pile-up probability. The expected count rate (including background) for the proposed setup reaches several Mcps, cf. fig. 2. This detector load is quite challenging [30], but as only one detector with individual readout is deployed, it can be addressed with sophisticated pile-up fitting algorithms, as shown by [77], [78], and state-of-the-art single-channel digitizers.

F. Radiation background

The presence of neutron-induced background is a critical factor that might affect the precision of the method. A proportional ratio k¯γ has been adopted in this study, but experimental measurements are needed to develop a more realistic model depending on the incident proton energy, as well as to verify the absolute yield. Additionally, the increase in neutron fluence in forward direction [40] has to be incorporated in the model. The downstream position of the CPGM detector is a double-edged sword: it maximizes the sensitivity to prompt γ-rays near the Bragg peak, but at the price of an increase in neutron-induced background.

A large radiation background is inconvenient for the CPGM technique due to two reasons. First, it leads to a very high detector count rate, especially at high initial proton energies, that challenges the electronics design. Second, it might bias the estimate of the integral number of prompt γ-rays, as the subtraction of neutron-induced background based on timing measurements [35] is accomplished experimentally with semi-empirical algorithms [21]. Ideally, the neutron-induced background should be fully modeled and incorporated as a measurement value [79] in addition to prompt γ-rays, as it carries residual information about the proton range, cf. fig. 10. However, the neutron interaction processes are complicated to model and strongly depend on the surrounding materials in the treatment room, which are not well characterized.

G. Integration in treatment room

In general, range verification techniques comprise several detection units [16], [28], [29], [80]. Some prototypes deploy a thick collimator and a heavy supporting frame [21, Fig. 10], [81, Fig. 4], which poses an engineering challenge in case of an integration with the rotating gantry to match any beam angle. In contrast, the CPGM is a minimalistic approach using a single detection unit and no collimator. A model of a gantry treatment room with the CPGM detector setup attached to the patient couch is illustrated in fig. 11. The estimated detector weight is below 500 g, and the weight of an articulating arm is below 9 kg. Due to the compactness of the proposed system, its integration seems less complex and more affordable than for other PGI methods, and is especially promising for treatment rooms with space constraints [24].

Fig. 11.

Fig. 11.

3D model of the proposed detection setup in a proton treatment room. The beam incidence angle is horizontal and the irradiated area is the patient’s intracranial region. The scintillation detector (red) is behind the treated area and coaxial to the beam, and is mounted on a rotating arm (green) that is attached to the patient couch. The X-ray panels (top and right) can be used for measuring the detector position relative to the patient without interfering the treatment. The number of γ-ray detections per unit proton is correlated to the beam range. Note that the chosen geometry is compatible with the frequent brain treatment scenario with no couch rotation [51].

H. System alignment

One important aspect of range verification devices based on PGI is the system alignment with respect to the room isocenter, e.g. with embedded lasers [21]. The positioning uncertainty along the beam direction and the alignment reproducibility are critical, and can be the main limiting factor for the achievable range precision [20]. Moreover, the heavier the system, the more efforts are needed to achieve the required precision, even more if the γ-ray camera rotates to match the beam incidence angle.

For the CPGM approach, we can benefit from the small footprint of the detector as well as its position close to the patient. The in-room orthogonal radiographies used for patient positioning in the clinical workflow are very convenient for detector positioning, as the detector setup does not collide with the two extended X-ray panels, cf. fig. 11. It is also not mandatory to place the detector at the exact same position for every treatment fraction. It is rather necessary to know accurately its position with respect to the patient. The two orthogonal X-ray images can offer a sub-millimeter resolution [82] of the 3D detector position, that can be directly mapped to the beam coordinate system.

I. Compatibility and applicability

Range verification devices based on PGI are usually designed for a specific type of proton accelerator used at the developing institution. Consequently, the results cannot be directly translated to other types of accelerators, since the expected beam current and beam time structure [30], [54], [83] might be drastically different. In the case of CPGM, we focus on the most widespread accelerator type [84], and the conclusions drawn in this study might potentially not be extrapolated to facilities with a different machine type.

Concerning the versatility of PGI devices, due to their footprint, a single design cannot be applied in general for every treatment site and every possible patient couch angle so far. Thus, it is convenient to focus first on the most common treatment sites, as well as those who would benefit most of an in vivo range verification. In this study, we choose the treatment of brain tumors from a horizontal incidence angle, and no patient couch rotation, as it is common in clinical practice [51]. It should be noted that the study is extensible to other beam incidence angles, as the detector can rotate accordingly around the head, cf. fig. 11.

In general terms, the precision of the method increases the closer the detector is to the Bragg peak. Thus, women could potentially benefit more than men from the CPGM technique due to their smaller average head breadth [53]. This would be also the case for pediatric tumors. The extensibility of this approach to other treatment sites depends on the particular beam incidence and patient couch angle. In the case of a prostate treatment from a horizontal beam angle, the coaxial detector position downstream would be far away from the Bragg peak. The range measurement could be done with ease, but the achievable precision would diminish. One alternative could be to move the detector slightly off the beam axis, so that it can reach a closer position to the Bragg peak from above the patient.

J. Price estimate

The literature about the cost of PGI prototypes is scarce due to early stage of research development and the several years remaining until a final product is actually commercialized. Some rough estimates state an overall material cost of at least 200 k$ [29] and up to 1 M$ [85], not accounting for development, commissioning and maintenance. Furthermore, these costs do not include the potential integration in the rotating gantry structure, for covering several beam incidence angles.

The cost-effectiveness of range verification devices is important taking into account its potential applicability in every treatment room of every proton center. Being an optional quality assurance device, not essential for the treatment, the benefits provided by improving the delivery precision should not be burdened by a prohibitive cost in addition to the already expensive proton facility [86], [87]. While there is consensus that PGI devices are able to provide useful information for proton range determination, it is still questionable whether they will manage to offer it at an affordable price, especially in the case of Compton cameras [31]. There is a trend towards simpler range verification solutions [26]–[28] that do not ensure an accuracy as high as already existing prototypes [21], [43], but that might have an easier translation to all clinics due its lower cost [88].

In the case of the CPGM technique, designed for minimum expense and impact on the treatment room, while keeping an acceptable range precision, we provide a budget estimate in table II based on quotations from year 2019. The total material cost is expected to be about 25 k$.

TABLE II.

Rough estimate of the material costs (budgetary price as of 2019) of a CPGM device for proton range verification in a clinical treatment room.

Item Amount / $
Detector
ø1×1½ scintillation crystal 6,000
ø1 fast PMT 1,000
(7,000)
Electronics
 Voltage divider and High Voltage (HV) supply 1,000
 Fast amplifier 1,000
 Power supply and circuit board 1,000
(3,000)
Data acquisition
 Fast single-channel digitizer 5,000
 High-end computer 7,000
(12,000)
Mechanics
 Articulating arm 2,000
 Detector mount 1,000
(3,000)

Total Material Cost 25,000

K. Overview

Table III summarizes the Strengths, Weaknesses, Opportunities and Threats (SWOT) of the CPGM method described throughout the manuscript. The simplicity of the design using a single detector is one big advantage. Its small footprint and low weight allow for a seamless integration with the couch of the treatment room for any incidence angle. If a proof-of-principle experiment validates the CPGM method, it would become an ideal candidate for in vivo range verification in compact proton treatment rooms. At the same time, it does not interfere with the embedded X-ray panels. They could be used for accurate detector positioning, and no additional laser alignment system is needed. Furthermore, the method does not directly depend on the bunch time structure, one of the challenges faced in the PGT technique [54]. Altogether, this minimalist setup might enable range verification at an affordable price of 25 k$.

TABLE III.

Analysis of Strengths, Weaknesses, Opportunities and Threats (SWOT) of the CPGM method.

Strengths Weaknesses
Single detector, no collimator
Compactness
Lightweight
Integration with gantry
Alignment with X-ray panels
Independent on bunch structure
Affordable
Dependence on proton number
Efficiency calibration
Attenuation coefficients
Nuclear concentration
Shallow treatment sites
Extension to two detectors
Slightly off-axis
Dual-energy CT
Integration with PGT
Integration with PGS
Combination with PET
Widespread applicability
Challenging count rate
Neutron-induced background
Nuclear cross sections
New accelerators
Opportunities Threats

A disadvantage of the CPGM method is the dependence on the incident number of protons, which is given by the ionization chamber within the beamline. The chamber has to be calibrated very accurately and compensated for pressure or temperature variations. Likewise, the detector response needs to be precisely characterized, and the scintillation crystal aging has to be monitored. Temperature effects on the light yield and PMT gain should be corrected with stabilization techniques [89]. Furthermore, a good knowledge of the γ-ray attenuation coefficients in the patient volume behind the treated area is mandatory. The correct estimation of the nuclear concentration within the irradiated area is also essential. Aside from that, another disadvantage is that the distance across the beam axis between detector and treated volume should be as small as possible. Hence, not all treatment sites or patients may benefit from this technique with the same precision. Women and especially children might be more indicated than adult men (on average) for a precise range verification with CPGM.

Other difficulty faced by the CPGM technique is the challenging high count rates in the detector, in part due to the increased neutron-induced background in downstream positions. The radiation background has been roughly estimated but has to be verified experimentally. Also, the CPGM technique depends on nuclear reaction cross section data, which currently suffer from large uncertainties. Aside from that, a potential future obstacle (for any PGI device) is the increase of the instantaneous beam current in the new accelerators like the synchrocyclotron S2C2 from IBA [83], that leads to much higher detector count rates. This would force a challenging research towards the use of faster scintillation materials, e.g. BaF2, PbWO4, PrBr3 [42] or plastic, than the one deployed in this study, at the price of a worse energy resolution.

Given the aforementioned disadvantages and potential obstacles, there is room for improvement and possible workarounds. One promising way is the addition of a second detector in an upstream position. Both detectors would be sensitive to complementary regions of the patient, which could potentially mitigate errors due to the uncertainty of the nuclear reaction cross sections and even cancel the dependency on the incoming number of protons. A shift of the downstream detector to slightly off-axis angles might also reduce the neutron-induced background, while still keeping a strong dependency of registered γ-rays with penetration depth. Furthermore, information obtained by CPGM could be combined with that derived from PGS or PGT techniques, but using the same single detector (and no collimator). These can provide additional information to reduce the error in the assumed nuclear concentrations and absolute proton range. Moreover, there might be the possibility to measure the integral number of annihilation photons during beam pauses, as with in-beam PET [16]. This could also provide further insights about absolute proton ranges in patients. Of course, a compromise has to be found between the additional information gained by integrating further methods within CPGM, and the complexity and price that it might add to the method. A simple and robust method with an acceptable accuracy could potentially have more opportunities to become a widespread application in clinic routine.

V. Conclusions

A method for range verification in proton therapy based on the acquisition of coaxial prompt γ-rays is presented, which is referred to as Coaxial Prompt Gamma-ray Monitoring (CPGM). In contrast to other PGI prototypes comprising several detection units located perpendicularly or upstream of the beam axis, we propose a single γ-ray detector without collimation positioned coaxially to the proton beam incidence direction. In this particular geometry, and assuming ideal homogeneous phantoms and well-known detector response, the integral number of prompt γ-rays measured encodes the proton range.

Based on a simplified theoretical model of prompt γ-ray emission and detection, the sensitivity of CPGM to virtual range deviations is estimated. For a single ø1×1½ LaBr3 scintillation detector positioned behind a 150 mm water target, we predict a change of more than 3% in the measured number of γ-rays for a global range error of 1 mm. Assuming a spot cluster with 108 protons, the measurement precision would be enough to detect such a variation with a 1σ significance. This compact method could be easily applied in the clinics and would have a seamless integration within the gantry treatment room.

Our theoretical investigation is the first step towards an experimental proof-of-principle study in a proton therapy facility. This experiment has to discern whether the approximations assumed in the model are legitimate and the proposed method can be realistically applied in a clinical scenario. Especially, the predicted neutron-induced background in forward direction and the ability of the detector to cope with very high count rates have to be confirmed. Furthermore, the prompt γ-ray yields and detector response have to be characterized and calibrated with a very high precision.

Ultimately, the CPGM method could enable proton range verification at a more affordable price than other PGI prototypes with heavy collimators and multiple detectors, while keeping an acceptable accuracy. Specifically, we aim at monitoring the proton range deviations with a precision of σ = 1 mm for a spot cluster of 108 protons, at a clinical beam current of 2 nA, setup costs of 25 k$ and a weight below 10 kg. The eventual achievement of this milestone could facilitate a widespread application of in vivo range verification in proton therapy facilities, in order to improve the quality of patient treatment.

Acknowledgement

We thank P. Botas, L. M. Fraile, C. Golnik, B. Gorissen, A. Hammi, T. Kögler, H. Paganetti, G. Pausch, J. Petzoldt, T. A. Ruggieri, J. Shin, S. Tattenberg, J. M. Udias, J. M. Verburg, A. Wagner and P. Wohlfahrt for scientific advice and discussions. This work was supported in part by the Federal Share of program income earned by Massachusetts General Hospital on C06-CA059267, Proton Therapy Research and Treatment Center.

References

  • [1].PTCOG, “Patient statistics and facilities under operation,” Particle Therapy Co-Operative Group, 2017. https://www.ptcog.ch/index.php/patient-statistics [Google Scholar]
  • [2].Newhauser WD and Zhang R, “The physics of proton therapy,” Phys. Med. Biol, vol. 60, no. 8, p. R155, 2015. 10.1088/0031-9155/60/8/R155 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Tian X, Liu K, Hou Y, Cheng J, and Zhang J, “The evolution of proton beam therapy: Current and future status (review),” Mol Clin Oncol, vol. 8, no. 1, pp. 15–21, 2018. 10.3892/mco.2017.1499 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Amaldi U and Kraft G, “Radiotherapy with beams of carbon ions,” Rep. Prog. Phys, vol. 68, no. 8, p. 1861, 2005. 10.1088/0034-4885/68/8/R04 [DOI] [Google Scholar]
  • [5].Glimelius B, Ask A, Bjelkengren G, Bjork-Eriksson T, Blomquist E, Johansson B, Karlsson M, and Zackrisson B, “Number of patients potentially eligible for proton therapy,” Acta Oncol, vol. 44, no. 8, pp. 836–849, 2005. 10.1080/02841860500361049 [DOI] [PubMed] [Google Scholar]
  • [6].Knopf A-C and Lomax A, “In vivo proton range verification: a review,” Phys. Med. Biol, vol. 58, no. 15, p. R131, 2013. 10.1088/0031-9155/58/15/R131 [DOI] [PubMed] [Google Scholar]
  • [7].Andreo P, “On the clinical spatial resolution achievable with protons and heavier charged particle radiotherapy beams,” Phys. Med. Biol, vol. 54, no. 11, p. N205, 2009. 10.1088/0031-9155/54/11/N01 [DOI] [PubMed] [Google Scholar]
  • [8].Albertini F, Hug EB, and Lomax AJ, “Is it necessary to plan with safety margins for actively scanned proton therapy?” Phys. Med. Biol, vol. 56, no. 14, p. 4399, 2011. 10.1088/00319155/56/14/011 [DOI] [PubMed] [Google Scholar]
  • [9].Hueso-González F, Fiedler F, Golnik C, Kormoll T, Pausch G, Petzoldt J, Römer KE, and Enghardt W, “Compton camera and prompt gamma ray timing: two methods for in vivo range assessment in proton therapy,” Front. Oncol, vol. 6, no. 80, 2016. 10.3389/fonc.2016.00080 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Unkelbach J, Chan TCY, and Bortfeld T, “Accounting for range uncertainties in the optimization of intensity modulated proton therapy,” Phys. Med. Biol, vol. 52, no. 10, p. 2755, 2007. 10.1088/0031-9155/52/10/009 [DOI] [PubMed] [Google Scholar]
  • [11].Polf J and Parodi K, “Imaging particle beams for cancer treatment,” Phys Today, vol. 68, no. 10, p. 28, 2015. 10.1063/PT.3.2945 [DOI] [Google Scholar]
  • [12].Parodi K and Polf JC, “In vivo range verification in particle therapy,” Med Phys, vol. 45, no. 11, pp. e1036–e1050, 2018. 10.1002/mp.12960 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Parodi K, Enghardt W, and Haberer T, “In-beam PET measurements of β+ radioactivity induced by proton beams,” Phys. Med. Biol, vol. 47, no. 1, p. 21, 2002. 10.1088/0031-9155/47/1/302 [DOI] [PubMed] [Google Scholar]
  • [14].Smeets J, Roellinghoff F et al. , “Prompt gamma imaging with a slit camera for real-time range control in proton therapy,” Phys. Med. Biol, vol. 57, no. 11, p. 3371, 2012. 10.1088/0031-9155/57/11/3371 [DOI] [PubMed] [Google Scholar]
  • [15].Kraan AC, “Range verification methods in particle therapy: underlying physics and Monte Carlo modelling,” Front. Oncol, vol. 5, no. 150, 2015. 10.3389/fonc.2015.00150 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16].Buitenhuis HJT, Diblen F, Brzezinski KW, Brandenburg S, and Dendooven P, “Beam-on imaging of short-lived positron emitters during proton therapy,” Phys Med Biol, vol. 62, no. 12, pp. 4654–4672, 2017. 10.1088/1361-6560/aa6b8c [DOI] [PubMed] [Google Scholar]
  • [17].Jongen Y and Stichelbaut F, “Verification of the proton beam position in the patient by the prompt gamma rays emission,” in PTCOG Conf Rec, 2003, p. 16 https://www.ptcog.ch/archive/steering_committee_docs/ptcog39-2003/2003_PTCOG_39_Abstracts.pdf [Google Scholar]
  • [18].Krimmer J, Dauvergne D, Létang J, and Testa E, “Prompt-gamma monitoring in hadrontherapy: A review,” Radiat Ima Tech Appl, vol. 878, pp. 58–73, 2018. 10.1016/j.nima.2017.07.063 [DOI] [Google Scholar]
  • [19].Richter C, Pausch G et al. , “First clinical application of a prompt gamma based in vivo proton range verification system,” Radioth Oncol, vol. 118, no. 2, pp. 232–237, 2016. 10.1016/j.radonc.2016.01.004 [DOI] [PubMed] [Google Scholar]
  • [20].Xie Y, Bentefour EH et al. , “Prompt gamma imaging for in vivo range verification of pencil beam scanning proton therapy,” Int. J. Radiat. Oncol. Biol. Phys, vol. 99, no. 1, pp. 210–218, 2017. 10.1016/j.ijrobp.2017.04.027 [DOI] [PubMed] [Google Scholar]
  • [21].Hueso-González F, Rabe M, Ruggieri TA, Bortfeld T, and Verburg JM, “A full-scale clinical prototype for proton range verification using prompt gamma-ray spectroscopy,” Phys Med Biol, vol. 63, no. 18, p. 185019, 2018. 10.1088/1361-6560/aad513 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22].Schippers JM, “Miniaturizing proton therapy: A technical challenge with unclear clinical impact,” Int J Radiat Oncol Biol Phys, vol. 95, no. 1, pp. 149–153, 2016, particle Therapy Special Edition. 10.1016/j.ijrobp.2016.02.030 [DOI] [PubMed] [Google Scholar]
  • [23].Farr JB, Flanz JB, Gerbershagen A, and Moyers MF, “New horizons in particle therapy systems,” Med Phys, vol. 45, no. 11, pp. e953–e983, 2018. 10.1002/mp.13193 [DOI] [PubMed] [Google Scholar]
  • [24].Slopsema R, “Squeezing the proton towards small proton therapy systems,” FLAAPM Fall Meeting, 2014. http://hpschapters.org/florida/PPPT7.pdf [Google Scholar]
  • [25].Bortfeld TR and Loeffler JS, “Three ways to make proton therapy affordable,” Nature, vol. 549, no. 7673, pp. 451–453, 2017. 10.1038/549451a [DOI] [PubMed] [Google Scholar]
  • [26].Assmann W, Kellnberger S et al. , “Ionoacoustic characterization of the proton Bragg peak with submillimeter accuracy,” Med. Phys, vol. 42, no. 2, pp. 567–574, 2015. 10.1118/1.4905047 [DOI] [PubMed] [Google Scholar]
  • [27].Golnik C, Hueso-González F et al. , “Range assessment in particle therapy based on prompt γ-ray timing measurements,” Phys. Med. Biol, vol. 59, no. 18, p. 5399, 2014. 10.1088/0031-9155/59/18/5399 [DOI] [PubMed] [Google Scholar]
  • [28].Krimmer J, Angellier G et al. , “A cost-effective monitoring technique in particle therapy via uncollimated prompt gamma peak integration,” Appl. Phys. Lett, vol. 110, no. 15, p. 154102, 2017. 10.1063/1.4980103 [DOI] [Google Scholar]
  • [29].Draeger E, Mackin D, Peterson S, Chen H, Avery S, Beddar S, and Polf JC, “3D prompt gamma imaging for proton beam range verification,” Phys. Med. Biol, vol. 63, no. 3, p. 035019, 2018. 10.1088/1361-6560/aaa203 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [30].Pausch G, Berthold J, Enghardt W, Römer K, Straessner A, Wagner A, Werner T, and Kögler T, “Detection systems for range monitoring in proton therapy: Needs and challenges,” Nucl Instr Methods Phys Res A, 2018. 10.1016/j.nima.2018.09.062 [DOI] [Google Scholar]
  • [31].Hueso-González F, Pausch G, Petzoldt J, Römer KE, and Enghardt W, “Prompt gamma rays detected with a BGO block Compton camera reveal range deviations of therapeutic proton beams,” IEEE Trans Radiat Plasma Med Sci, vol. 1, no. 1, pp. 76–86, 2017. 10.1109/TNS.2016.2622162 [DOI] [Google Scholar]
  • [32].Lee E, Polf JC, Mackin DS, Beddar S, Dolney D, Ainsley C, Kassaee A, and Avery S, “Study of the angular dependence of a prompt gamma detector response during proton radiation therapy,” Int J Part Ther, vol. 1, no. 3, pp. 731–744, 2014. 10.14338/IJPT-14-00012.1 [DOI] [Google Scholar]
  • [33].Hueso-González F, “Nuclear methods for real-time range verification in proton therapy based on prompt gamma-ray imaging,” 2016. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-204988
  • [34].Panaino C, Mackay R, Merchant M, Green S, Phoenix B, Price T, Kirkby K, and Taylor M, “Range uncertainty reduction in proton beam therapy via prompt gamma-ray detection,” in Phys Med, 2nd European Congress of Medical Physics, vol. 52, 2018, p. 23 10.1016/j.ejmp.2018.06.128 [DOI] [PubMed] [Google Scholar]
  • [35].Biegun AK, Seravalli E et al. , “Time-of-flight neutron rejection to improve prompt gamma imaging for proton range verification: a simulation study,” Phys. Med. Biol, vol. 57, no. 20, p. 6429, 2012. 10.1088/0031-9155/57/20/6429 [DOI] [PubMed] [Google Scholar]
  • [36].Verburg JM, Riley K, Bortfeld T, and Seco J, “Energy- and time-resolved detection of prompt gamma-rays for proton range verification,” Phys. Med. Biol, vol. 58, no. 20, p. L37, 2013. 10.1088/0031-9155/58/20/L37 [DOI] [PubMed] [Google Scholar]
  • [37].Berger M, Hubbell J, abd J SS Chang J. Coursey, Sukumar R, Zucker D, and Olsen K, “XCOM: Photon Cross Section Database, NIST Standard Reference Database 8 (XGAM),” NIST, 2010. http://www.nist.gov/pml/data/xcom [Google Scholar]
  • [38].Shelyuto VA, “Exact analytic results for the solid angle in systems with axial symmetry,” Z. Angew. Math. Phys, vol. 40, no. 4, pp. 608–612, 1989. 10.1007/BF00944811 [DOI] [Google Scholar]
  • [39].Conway JT, “Analytical solution for the solid angle subtended at any point by an ellipse via a point source radiation vector potential,” Nucl Instr Methods Phys Res A, vol. 614, no. 1, pp. 17–27, 2010. 10.1016/j.nima.2009.11.075 [DOI] [Google Scholar]
  • [40].Zarifi M, Guatelli S, Bolst D, Hutton B, Rosenfeld A, and Qi Y, “Characterization of prompt gamma-ray emission with respect to the Bragg peak for proton beam range verification: A Monte Carlo study,” Phys Med, vol. 33, pp. 197–206, 2017. 10.1016/j.ejmp.2016.12.011 [DOI] [PubMed] [Google Scholar]
  • [41].Polf JC, Mackin D, Lee E, Avery S, and Beddar S, “Detecting prompt gamma emission during proton therapy: the effects of detector size and distance from the patient,” Phys Med Biol, vol. 59, no. 9, pp. 2325–2340, 2014. 10.1088/0031-9155/59/9/2325 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [42].Glodo J, van Loef EVD, Kyba C, Karp JS, and Shah KS, “CeBr3-PrBr3 scintillators,” in IEEE Nucl Sci Symp Conf Rec, vol. 3, 2007, pp. 2178–2181. 10.1109/NSSMIC.2007.4436583 [DOI] [Google Scholar]
  • [43].Nenoff L, Priegnitz M, Janssens G, Petzoldt J, Wohlfahrt P, Trezza A, Smeets J, Pausch G, and Richter C, “Sensitivity of a prompt-gamma slit-camera to detect range shifts for proton treatment verification,” Radioth Oncol, vol. 125, no. 3, pp. 534–540, 2017. 10.1016/j.radonc.2017.10.013 [DOI] [PubMed] [Google Scholar]
  • [44].Jeyasugiththan J and Peterson SW, “Evaluation of proton inelastic reaction models in Geant4 for prompt gamma production during proton radiotherapy,” Phys Med Biol, vol. 60, no. 19, pp. 7617–7635, 2015. 10.1088/0031-9155/60/19/7617 [DOI] [PubMed] [Google Scholar]
  • [45].Cambraia Lopes P, Crespo P, Huizenga J, and Schaart DR, “Optimization of the signal-to-background ratio in prompt gamma imaging using energy and shifting time-of-flight discrimination: Experiments with a scanning parallel-slit collimator,” IEEE Trans Radiat Plasma Med Sci, vol. 2, no. 5, pp. 510–519, 2018. 10.1109/TRPMS.2018.2846612 [DOI] [Google Scholar]
  • [46].Pinto M, Bajard M et al. , “Absolute prompt-gamma yield measurements for ion beam therapy monitoring,” Phys. Med. Biol, vol. 60, no. 2, p. 565, 2015. 10.1088/0031-9155/60/2/565 [DOI] [PubMed] [Google Scholar]
  • [47].Hueso-González F, Enghardt W et al. , “First test of the prompt gamma ray timing method with heterogeneous targets at a clinical proton therapy facility,” Phys. Med. Biol, vol. 60, no. 16, p. 6247, 2015. 10.1088/0031-9155/60/16/6247 [DOI] [PubMed] [Google Scholar]
  • [48].Perali I, Celani A et al. , “Prompt gamma imaging of proton pencil beams at clinical dose rate,” Phys. Med. Biol, vol. 59, no. 19, p. 5849, 2014. 10.1088/0031-9155/59/19/5849 [DOI] [PubMed] [Google Scholar]
  • [49].Testa M, “Charged particle therapy, ion range verification, prompt radiation,” Ph.D. dissertation, Université Claude Bernard - Lyon I, 2010. https://tel.archives-ouvertes.fr/tel-00566188 [Google Scholar]
  • [50].ASTRO, “Proton beam therapy: Model policy,” 2014. https://www.astro.org/Daily-Practice/Reimbursement/Model-Policies
  • [51].Yan S, Lu H-M, Flanz J, Adams J, Trofimov A, and Bortfeld T, “Reassessment of the necessity of the proton gantry: Analysis of beam orientations from 4332 treatments at the Massachusetts General Hospital proton center over the past 10 years,” Int J Radiat Oncol Biol Phys, vol. 95, no. 1, pp. 224–233, 2016. 10.1016/j.ijrobp.2015.09.033 [DOI] [PubMed] [Google Scholar]
  • [52].Taasti VT, Bäumer C et al. , “Inter-centre variability of CT-based stopping-power prediction in particle therapy: Survey-based evaluation,” Phys Imaging Radiat Oncol, vol. 6, pp. 25–30, 2018. 10.1016/j.phro.2018.04.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [53].Zhuang Z and Bradtmiller B, “Head-and-face anthropometric survey of U.S. respirator users,” J Occup Environ Hyg, vol. 2, no. 11, pp. 567–576, 2005. 10.1080/15459620500324727 [DOI] [PubMed] [Google Scholar]
  • [54].Petzoldt J, Roemer KE et al. , “Characterization of the microbunch time structure of proton pencil beams at a clinical treatment facility,” Phys. Med. Biol, vol. 61, no. 6, p. 2432, 2016. 10.1088/0031-9155/61/6/2432 [DOI] [PubMed] [Google Scholar]
  • [55].Perl J, Shin J, Schumann J, Faddegon B, and Paganetti H, “TOPAS: an innovative proton Monte Carlo platform for research and clinical applications,” Med. Phys, vol. 39, no. 11, pp. 6818–6837, 2012. 10.1118/1.4758060 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [56].Allison J, Amako K et al. , “Recent developments in Geant4,” Nucl. Instrum. Methods Phys. Res., Sect. A, vol. 835, pp. 186–225, 2016. 10.1016/j.nima.2016.06.125 [DOI] [Google Scholar]
  • [57].Berger M, Coursey J, Zucker M, and Chang J, “ESTAR, PSTAR, and ASTAR: Computer programs for calculating stopping-power and range tables for electrons, protons, and helium ions,” NIST, 2005. http://physics.nist.gov/Star [Google Scholar]
  • [58].Sheldon E and Van Patter DM, “Compound inelastic nucleon and gamma-ray angular distributions for even- and odd-mass nuclei,” Rev Mod Phys, vol. 38, no. 1, pp. 143–186, 1966. 10.1103/RevModPhys.38.143 [DOI] [Google Scholar]
  • [59].Shute GG and Baxter AM, “Angular correlations for 12C(p,p’γ)12C,” Nucl Phys, vol. 83, no. 2, pp. 460–480, 1966. 10.1016/0029-5582(66)90584-0 [DOI] [Google Scholar]
  • [60].Kiener J, Berheide M, Achouri NL, Boughrara A, Coc A, Lefebvre A, de Oliveira Santos F, and Vieu C, “γ-ray production by inelastic proton scattering on 16O and 12C,” Phys Rev C, vol. 58, no. 4, pp. 2174–2179, 1998. 10.1103/PhysRevC.58.2174 [DOI] [Google Scholar]
  • [61].Mattei I, Battistoni G et al. , “Prompt-γ production of 220 MeV/u 12C ions interacting with a PMMA target,” J. Instrum, vol. 10, no. 10, p. P10034, 2015. 10.1088/1748-0221/10/10/P10034 [DOI] [Google Scholar]
  • [62].Lu Y, Song Z-H, Li G, Tan X-J, Zhao X-C, and Zhang K, “Study of neutron radiation effect in LaBr3 scintillator,” Chinese Phys C, vol. 39, no. 10, p. 106003, 2015. 10.1088/1674-1137/39/10/106003 [DOI] [Google Scholar]
  • [63].Cazzaniga C, Nocente M, Tardocchi M, Rebai M, Pillon M, Camera F, Giaz A, Pellegri L, and Gorini G, “Response of LaBr3(Ce) scintillators to 14 MeV fusion neutrons,” Nucl Instr Methods Phys Res A, vol. 778, pp. 20–25, 2015. 10.1016/j.nima.2015.01.002 [DOI] [Google Scholar]
  • [64].Lens E, Jagt TZ, Hoogeman MS, and Schaart DR, “Correlations between the shifts in prompt gamma emission profiles and the changes in daily target coverage during simulated pencil beam scanning proton therapy,” Phys Med Biol, vol. 64, no. 8, p. 085009, 2019. 10.1088/1361-6560/ab145e [DOI] [PubMed] [Google Scholar]
  • [65].Sterpin E, Janssens G, Smeets J, Stappen FV, Prieels D, Priegnitz M, Perali I, and Vynckier S, “Analytical computation of prompt gamma ray emission and detection for proton range verification,” Phys Med Biol, vol. 60, no. 12, pp. 4915–4946, 2015. 10.1088/0031-9155/60/12/4915 [DOI] [PubMed] [Google Scholar]
  • [66].Dedes G, Pinto M, Dauvergne D, Freud N, Krimmer J, Létang JM, Ray C, and Testa E, “Assessment and improvements of Geant4 hadronic models in the context of prompt-gamma hadrontherapy monitoring,” Phys Med Biol, vol. 59, no. 7, pp. 1747–1772, 2014. 10.1088/0031-9155/59/7/1747 [DOI] [PubMed] [Google Scholar]
  • [67].Verburg JM, Shih HA, and Seco J, “Simulation of prompt gamma-ray emission during proton radiotherapy,” Phys. Med. Biol, vol. 57, no. 17, p. 5459, 2012. 10.1088/0031-9155/57/17/5459 [DOI] [PubMed] [Google Scholar]
  • [68].Toscano S, Souris K, Gomà C, Barragán-Montero A, Puydupin S, Stappen FV, Janssens G, Matic A, Geets X, and Sterpin E, “Impact of machine log-files uncertainties on the quality assurance of proton pencil beam scanning treatment delivery,” Phys Med Biol, vol. 64, no. 9, p. 095021, 2019. 10.1088/1361-6560/ab120c [DOI] [PubMed] [Google Scholar]
  • [69].Kiener J, “Shape and angular distribution of the 4.439-MeV γ-ray line from proton inelastic scattering off 12C,” Phys. Rev. C, vol. 99, no. 1, p. 014605, 2019. 10.1103/PhysRevC.99.014605 [DOI] [Google Scholar]
  • [70].Kögler T, “Proton-induced prompt gamma-ray yield of carbon for range verification in hadron therapy,” in Nuclear Data Conf, 2019. http://static.medmeeting.org/Upload/user/1539731/file/20190522/20190522130434_3244 [Google Scholar]
  • [71].Verburg JM and Seco J, “Proton range verification through prompt gamma-ray spectroscopy,” Phys. Med. Biol, vol. 59, no. 23, p. 7089, 2014. 10.1088/0031-9155/59/23/7089 [DOI] [PubMed] [Google Scholar]
  • [72].Wohlfahrt P, Möhler C, Richter C, and Greilich S, “Evaluation of stopping-power prediction by dual- and single-energy computed tomography in an anthropomorphic ground-truth phantom,” Int J Radiat Oncol Biol Phys, vol. 100, no. 1, pp. 244–253, 2018. 10.1016/j.ijrobp.2017.09.025 [DOI] [PubMed] [Google Scholar]
  • [73].Wohlfahrt P, Möhler C, Stützer K, Greilich S, and Richter C, “Dual-energy CT based proton range prediction in head and pelvic tumor patients,” Radioth Oncol, vol. 125, no. 3, pp. 526–533, 2017. 10.1016/j.radonc.2017.09.042 [DOI] [PubMed] [Google Scholar]
  • [74].Wohlfahrt P, Troost EG, Hofmann C, Richter C, and Jakobi A, “Clinical feasibility of single-source dual-spiral 4D dual-energy CT for proton treatment planning within the thoracic region,” Int J Radiat Oncol Biol Phys, vol. 102, no. 4, pp. 830–840, 2018. 10.1016/j.ijrobp.2018.06.044 [DOI] [PubMed] [Google Scholar]
  • [75].Wohlfahrt P, Möhler C, Hietschold V, Menkel S, Greilich S, Krause M, Baumann M, Enghardt W, and Richter C, “Clinical implementation of dual-energy CT for proton treatment planning on pseudo-monoenergetic CT scans,” Int J Radiat Oncol Biol Phys, vol. 97, no. 2, pp. 427–434, 2017. 10.1016/j.ijrobp.2016.10.022 [DOI] [PubMed] [Google Scholar]
  • [76].Werner T, Berthold J, Hueso-González F, Petzoldt J, Roemer K, Richter C, Rinscheid A, Straessner A, Enghardt W, and Pausch G, “Processing of prompt gamma-ray timing data for proton range measurements at a clinical beam delivery,” Phys Med Biol, vol. 64, no. 10, p. 105023, 2019. 10.1088/1361-6560/ab176d [DOI] [PubMed] [Google Scholar]
  • [77].Löher B, Savran D, Fiori E, Miklavec M, Pietralla N, and Vencelj M, “High count rate γ-ray spectroscopy with LaBr3:Ce scintillation detectors,” Nucl Instr Methods Phys Res A, vol. 686, pp. 1–6, 2012. 10.1016/j.nima.2012.05.051 [DOI] [Google Scholar]
  • [78].Mohammadian-Behbahani M-R and Saramad S, “Pile-up correction algorithm based on successive integration for high count rate medical imaging and radiation spectroscopy,” Nucl Instr Methods Phys Res A, vol. 897, pp. 1–7, 2018. 10.1016/j.nima.2018.04.028 [DOI] [Google Scholar]
  • [79].Ytre-Hauge KS, Skjerdal K, Mattingly J, and Meric I, “A Monte Carlo feasibility study for neutron based real-time range verification in proton therapy,” Sci Rep, vol. 9, no. 1, p. 2011, 2019. 10.1038/s41598-019-38611-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [80].Werner T, Berthold J et al. , “Range verification in proton therapy by prompt gamma-ray timing (PGT): Steps towards clinical implementation,” in IEEE Nucl Sci Symp Conf Rec, 2017, pp. 1–5. 10.1109/nssmic.2017.8532807 [DOI] [Google Scholar]
  • [81].Petzoldt J, Janssens G, Nenoff L, Richter C, and Smeets J, “Correction of geometrical effects of a knife-edge slit camera for prompt gamma-based range verification in proton therapy,” Instrum, vol. 2, no. 4, p. 25, 2018. 10.3390/instruments2040025 [DOI] [Google Scholar]
  • [82].Sharp GC, Kollipara S, Madden T, Jiang SB, and Rosenthal SJ, “Anatomic feature-based registration for patient set-up in head and neck cancer radiotherapy,” Phys Med Biol, vol. 50, no. 19, pp. 4667–4679, 2005. 10.1088/0031-9155/50/19/016 [DOI] [PubMed] [Google Scholar]
  • [83].van der Walle J, “Challenges in medical accelerator design,” Workshop on Medical Accelerator Design and Diagnostics, 2018. https://indico.cern.ch/event/744722/contributions/3089960/ [Google Scholar]
  • [84].PTCOG, “Facilities in operation,” 2019. https://www.ptcog.ch/index.php/facilities-in-operation
  • [85].Rohling H, Priegnitz M, Schoene S, Schumann A, Enghardt W, Hueso-González F, Pausch G, and Fiedler F, “Requirements for a Compton camera for in-vivo range verification of proton therapy,” Phys. Med. Biol, vol. 62, no. 7, p. 2795, 2017. 10.1088/1361-6560/aa6068 [DOI] [PubMed] [Google Scholar]
  • [86].Goitein M and Jermann M, “The relative costs of proton and x-ray radiation therapy,” Clin. Oncol, vol. 15, no. 1, pp. S37–S50, 2003. 10.1053/clon.2002.0174 [DOI] [PubMed] [Google Scholar]
  • [87].Peeters A, Grutters JP, Pijls-Johannesma M, Reimoser S, Ruysscher DD, Severens JL, Joore MA, and Lambin P, “How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons,” Radiother. Oncol, vol. 95, no. 1, pp. 45–53, 2010. 10.1016/j.radonc.2009.12.002 [DOI] [PubMed] [Google Scholar]
  • [88].Hueso-González F, Biegun AK et al. , “Comparison of LSO and BGO block detectors for prompt gamma imaging in ion beam therapy,” J. Instrum, vol. 10, no. 9, p. P09015, 2015. 10.1088/1748-0221/10/09/p09015 [DOI] [Google Scholar]
  • [89].Stein J, Kreuels A, Kong Y, Lentering R, Ruhnau K, Scherwinski F, and Wolf A, “Experiment and modeling of scintillation photon-counting and current measurement for PMT gain stabilization,” Nucl Instrum Methods Phys Res A, vol. 782, no. 0, pp. 20–27, 2015. 10.1016/j.nima.2015.01.101 [DOI] [Google Scholar]

RESOURCES